Intermittent Hypoxemia in Patients with Heart Failure with Preserved Ejection Fraction.
10.3881/j.issn.1000-503X.10198
- Author:
Jiang XIE
1
;
Fei LI
1
Author Information
1. Department of Respiratory and Critical Medicine,Beijing Anzhen Hospital,Capital Medical University,Beijing 100023,China.
- Publication Type:Journal Article
- MeSH:
Echocardiography;
Heart Failure;
complications;
Humans;
Hypoxia;
complications;
Oxygen;
blood;
Polysomnography;
Prognosis;
Retrospective Studies;
Sleep;
Stroke Volume
- From:
Acta Academiae Medicinae Sinicae
2018;40(6):785-789
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the characteristics of nocturnal intermittent hypoxemia in patients with heart failure(HF) with preserved ejection fraction(HFpEF).Methods Patients(n=854) who completed sleep test and echocardiography from January 2011 to December 2014 were retrospectively studied. HF patients with an ejection fraction(EF) of ≥50% were included in the HFpEF group(n=112) while HF patients with an EF of <50% included in the group of HF patients with reduced EF(HFrEF)(n=104). Respiratory events and minimum nocturnal saturation(minSaO) were recorded by home sleep testing,and the percentage of total sleep time with saturation <90%(T90SaO) were calculated.Results Compared with patients without HF,subjects with HFpEF and HFrEF had more breathing events[13(5,29)/h vs. 18(6,36)/h,and 21(8,45)/h,P<0.001],lower minSaO[85(80,87)% vs. 82(77,86)% and 83(78,87)%,P<0.001] and relatively longer T90SaO[3.0(0.4,15.5)% vs. 6.0(1.5,24.8)% and 6.7(1.3,14.4)%,P<0.001]. The HFpEF group had significantly higher odds of moderate-severe hypoxemia(minSaO<85%) during sleep than those without HF(OR=2.02,95%CI=1.34-3.11,P<0.001),with the significance persisting after adjusting for covariates including age,gender,hypertension,diabetes,coronary heart disease,renal dysfunction,and smoking(OR=1.85,95%CI=1.20-2.90,P=0.006).Conclusion Patients with HFpEF have frequent nocturnal intermittent hypoxemia,which warrants further investigations to evaluate if remission of night-time hypoxemia may improve long-term prognosis in this cohort.
